The LEAP India IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 7 August 2026. The LEAP India IPO closed on 11 August 2026, with an issue price of ₹159 per share. The LEAP India IPO has a face value of ₹1 and a lot size of 94 shares. The LEAP India IPO is listed on 14 August 2026. The LEAP India IPO allotment was scheduled for 12 August 2026.
On the financial front, the LEAP India IPO reported revenue of ₹747 crore for 31 Mar 2026, compared with ₹485 crore for 31 Mar 2025. The LEAP India IPO PAT was ₹62 crore against ₹38 crore. The LEAP India IPO EBITDA stood at ₹379 crore with a 50.69% margin. The LEAP India IPO net worth as of 31 Mar 2026 was ₹1,006 crore.
Always verify The LEAP India IPO details and GMP data with the official offer document before investing in the LEAP India IPO.
Financial Summary
Amount in ₹ Crore
Metric
31 Mar 2026
31 Mar 2025
31 Mar 2024
Total Assets
2,401
2,042
1,400
Revenue
747
485
372
PAT
62
38
37
EBITDA
379
274
210
Net Worth
1,006
917
714
Reserves
679
606
522
Total Borrowing
1,018
802
513
LEAP India IPO Financials FAQs
Revenue of LEAP India (Amount in ₹ Crore) — 31 Mar 2026: 747; 31 Mar 2025: 485; 31 Mar 2024: 372. Profit after tax (PAT) — 31 Mar 2026: 62; 31 Mar 2025: 38; 31 Mar 2024: 37.
EBITDA of LEAP India (Amount in ₹ Crore) — 31 Mar 2026: 379; 31 Mar 2025: 274; 31 Mar 2024: 210. The EBITDA margin is 50.69%.
Total assets — 31 Mar 2026: 2,401; 31 Mar 2025: 2,042; 31 Mar 2024: 1,400. Net worth — 31 Mar 2026: 1,006; 31 Mar 2025: 917; 31 Mar 2024: 714. Reserves & surplus — 31 Mar 2026: 679; 31 Mar 2025: 606; 31 Mar 2024: 522. (Amount in ₹ Crore)
Total borrowing of LEAP India (Amount in ₹ Crore) — 31 Mar 2026: 1,018; 31 Mar 2025: 802; 31 Mar 2024: 513. Debt-to-equity ratio: 1.01.
The financials shown for LEAP India IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
